Home ProductsPharmaceutical Raw Materials

Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder

Certification
Good quality Boldenone Steroid for sales
Good quality Boldenone Steroid for sales
Thanks for your professionalism with works ,your quality is very well for us!

—— Lionk-South Africa

Wow,you sent goods so Quickly!I am glad to work with you!

—— Jack-USA

Products are received well. I hope business will boom soon,Lots of order will come youre way.

—— Richard-Holland

test E 250. very little pip. less than a previous source. love the cialis

—— Peter-USA

Just wanted to tell you that the product so far have been amazing. All seem to be very good quality and where easy to cook. Very pleased with it and.

—— Han-Holland

I'm Online Chat Now

Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder

China Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder supplier
Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder supplier Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder supplier

Large Image :  Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder

Product Details:

Place of Origin: China
Brand Name: Yuancheng
Certification: ISO9001
Model Number: 94-24-6

Payment & Shipping Terms:

Minimum Order Quantity: Negotiable
Price: Negotiable
Packaging Details: Exquisite Package According to Your Requirements
Payment Terms: T/T, Western Union, MoneyGram,Bank Transfer
Supply Ability: 1000 kg per month
Contact Now
Detailed Product Description
Product Name: Pregabalin Appearance: White Powder
CAS: 148553-50-8 Assay: 99%
Molecular Formul: C8h17no2 Capacity: 2000kg

Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder

 

CAS:148553-50-8
MF:C8H17NO2
MW:159.23
Assay:99%
Appearance:White powder
Package:1kg/foil bag

 

Pregabalin is ananticonvulsant drug used for neuropathic pain and as an adjunct therapy for partial seizures with or without secondary generalization in adults. It has also been found effective for generalized anxiety disorder and is (as of 2007) approved for this use in the European Union. It was designed as a more potent successor to gabapentin. Pregabalin is marketed by Pfizer under the trade name Lyrica. Pfizer described in an SEC filing that the drug could be used to treat epilepsy, post-herpetic neuralgia and diabetic peripheral neuropathy, fibromyalgia, et al. Sales reached a record $3.063 billion in 2010.
Recent studies have shown that pregabalin is effective at treating chronic pain in disorders such as fibromyalgia and spinal cord injury. In June 2007, pregabalin became the first medication approved by the U.S.Food and Drug Administration specifically for the treatment offibromyalgia.
It is considered to have a low potential for abuse, and a limited dependence liability if misused, and is thus classified as a Schedule Vdrug in the U.S.
Lyrica is one of four drugs which a subsidiary of Pfizer in 2009 pleaded guilty to misbranding "with the intent to defraud or mislead". Pfizer agreed to pay $2.3 billion (£1.4 billion) in settlement, and entered a corporate integrity agreement. Pfizer illegally promoted the drugs and caused false claims to be submitted to government healthcare programs for uses that were not approved by the U.S. Food and Drug Administration(FDA).
Pregabalin is available in 25, 50, 75, 100, 150, 200, 225, and 300 mg capsules, and recently a strawberry-flavoured oral solution has been developed, containing 20 mg/mL with an added sweetening agent (sucrose) to mask the chemical's bitter taste. The maximum daily recommended dose for pregabalin is 600 mg. Dosages must be monitored and increases should be based on patient's tolerance.

Indication
Pregabalin is used for the management of neuropathic pain associated with diabetic peripheral neuropathy or spinal cord injury, and postherpetic neuralgia. It is also used as adjunctive therapy for adult patients with partial onset seizures and management of fibromyalgia.
Pharmacodynamics
Pregabalin is a new anticonvulsant drug indicated as an add on therapy for partial onset seizures and for certain types of neuropathic pain. It was designed as a more potent successor to a related drug, gabapentin. Pregabalin binds to the alpha2-delta subunit of the voltage-gated calcium channel in the central nervous system. While pregabalin is a structural derivative of the inhibitory neurotransmitter gamma- aminobutyric acid (GABA), it does not bind directly to GABAA, GABAB, or benzodiazepine receptors, does not augment GABAA responses in cultured neurons, does not alter rat brain GABA concentration or have acute effects on GABA uptake or degradation. However, in cultured neurons prolonged application of pregabalin increases the density of GABA transporter protein and increases the rate of functional GABA transport. Pregabalin does not block sodium channels, is not active at opiate receptors, and does not alter cyclooxygenase enzyme activity. It is inactive at serotonin and dopamine receptors and does not inhibit dopamine, serotonin, or noradrenaline reuptake.

Mechanism of action
Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of pregabalin is unknown, results with genetically modified mice and with compounds structurally related to pregabalin (such as gabapentin) suggest that binding to the alpha2-delta subunit may be involved in pregabalin's antinociceptive and antiseizure effects in animal models. In vitro, pregabalin reduces the calcium-dependent release of several neurotransmitters, possibly by modulation of calcium channel function. Studies also suggest that the descending noradrenergic and serotonergic pathways originating from the brainstem may be involved with the mechanism of pregabalin. Interestingly, although pregabalin is a structural derivative of inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors. The sodium channels, opiate receptors, and cyclooxygenase enzymes are not involved with the mechanism of pregabalin. It is also inactive at serotonin and dopamine receptors and does not inhibit dopamine, serotonin, or noradrenaline reuptake.

Competitive Advantage:
1 High quality with competitive price:
1) Standard: Enterprise Standard
2) All Purity≥98%
3) We are manufacturer and can provide high quality products with factory price.
2 Fast and safe delivery:
1) Parcel can be sent out in 24 hours after payment. Tracking number available
2) Secure and discreet shipment. Various transportation methods for your choice.
3) Customs pass rate ≥99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring.
3 We have clients throughout the world:
1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2) Market feedback and goods feedback will be appreciated, meeting customers' requirement is our responsibility.
3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers.

Pharmaceutical Raw Materials Pregabalin CAS: 148553-50-8 Solid White Powder

Contact Details
Wuhan Yuancheng Technology Development Co., Ltd.

Contact Person: Ron

Send your inquiry directly to us (0 / 3000)